LTR Pharma’s (ASX:LTP) joint venture partner, the Restorative Health Clinic (RHC), has launched an online healthcare platform ahead of the previously communicated Q1 2025 timeline. The platform, operated by RSHC, delivers comprehensive men’s health services through telehealth consultations.
“We’re thrilled to launch our online booking, consultation, and prescribing platform for men’s health,” Restorative Health Clinic Founder, Melissa Hadley Barrett, said.
“Our team of specialists is ready to provide evidence-based care for erectile dysfunction, combining personalised treatment with improved accessibility for Australian men."
RSHC's early launch reflects a strong interest in accessible healthcare solutions. The platform combines RSHC's clinical expertise in men’s health with access to innovative treatments, including but not limited to, LTR Pharma's SPONTAN, providing Australian men with convenient access to healthcare professionals and evidence-based treatments.
“This early launch by our joint venture partner demonstrates strong market demand for innovative healthcare solutions in men’s health. The platform provides an additional channel for delivering treatments, including SPONTAN, to Australian men via early access scheme pathways. We look forward to working with the RHC team to support the delivery of professional healthcare services in this growing online market,” LTR Pharma Executive Chairman, Lee Rodne, said.
The platform offers:
- Professional medical consultations by experts in treating erectile dysfunction
- Comprehensive therapeutic services in men’s health
- Prescription and non-prescription treatments
- Integrated health management solutions provided by RHC’s clinical team
